|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
30 Avenue Gustave Eiffel, Bat A, Pessac, Nouvelle-Aquitaine 33600, FR
|
|
TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.
TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.
Bringing together over 70 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M over the past 3 years to advance its pipeline of stem cell-based therapies in the field of neurodegeneration, cardio-metabolic disorders, and immuno-oncology. In 2022, the company will open technological hubs in Boston, USA, and Kobe, Japan, to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.
|
TreeFrog Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used TreeFrog Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact TreeFrog Therapeutics customer service number in your country click here to find.
Maxime Feyeux is the CEO of TreeFrog Therapeutics. To contact Maxime Feyeux email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.